These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
587 related items for PubMed ID: 32078894
21. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP. Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K. Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761 [Abstract] [Full Text] [Related]
24. Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning. Mirelman A, Ben Or Frank M, Melamed M, Granovsky L, Nieuwboer A, Rochester L, Del Din S, Avanzino L, Pelosin E, Bloem BR, Della Croce U, Cereatti A, Bonato P, Camicioli R, Ellis T, Hamilton JL, Hass CJ, Almeida QJ, Inbal M, Thaler A, Shirvan J, Cedarbaum JM, Giladi N, Hausdorff JM. Mov Disord; 2021 Sep; 36(9):2144-2155. PubMed ID: 33955603 [Abstract] [Full Text] [Related]
29. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. Manna I, Quattrone A, De Benedittis S, Vescio B, Iaccino E, Quattrone A. Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044 [Abstract] [Full Text] [Related]
30. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A. J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175 [Abstract] [Full Text] [Related]
31. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897 [Abstract] [Full Text] [Related]
32. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG, Shannon KL, Vaillancourt DE. PLoS One; 2013 Dec; 8(3):e58403. PubMed ID: 23505500 [Abstract] [Full Text] [Related]
34. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?]. Yamamoto T, Oya Y, Ogawa M, Ogata K, Kawai M. Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364 [Abstract] [Full Text] [Related]
35. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Cherubini A, Morelli M, Nisticó R, Salsone M, Arabia G, Vasta R, Augimeri A, Caligiuri ME, Quattrone A. Mov Disord; 2014 Feb; 29(2):266-9. PubMed ID: 24323617 [Abstract] [Full Text] [Related]